[Advances in systemic therapy-driven conversion strategies for locally advanced rectal cancer] [0.03%]
基于系统治疗的局部晚期直肠癌转化策略研究进展
X Y Li,S Chen,Q Yang et al.
X Y Li et al.
Locally advanced rectal cancer (LARC) remains a major therapeutic challenge in multidisciplinary oncology. The increasing emphasis on early systemic intervention has positioned total neoadjuvant therapy (TNT) as a central treatment paradigm...
[Interpretation of technical operation standards for modified Bacon procedure (2026 edition)] [0.03%]
[巴克纳氏手术改良技术操作规范解读（2026版）]
S Y Hu,Y Chang,X Y Hou et al.
S Y Hu et al.
Technical Operation Standards for Modified Bacon Surgery (2026 Edition) (hereinafter referred to as the Standards) aims to systematically standardize the operative techniques of this procedure and promote its standardized implementation. Th...
[Interpretation of expert consensus on primary tumor management for metastatic colorectal cancer (2026 edition)] [0.03%]
《转移性结直肠癌原发灶处理专家共识解读（2026版）》
N Chen,A W Wu
N Chen
The recently released Expert Consensus on the Management of Primary Tumor in Metastatic Colorectal Cancer (2026 Edition) represents a systematic update and paradigm shift in the management of the primary tumor, developed against the backdro...
[Technical operation standards for modified Bacon procedure (2026 edition)] [0.03%]
改良巴克手术技术操作规范（2026版）
Colorectal Cancer Committee of the Chinese Medical Doctor Association;Colorectal Cancer Committee of China Anti-Cancer Association;Natural Orifice Specimen Extraction Surgery (NOSES) Committee of China Anti-
Colorectal Cancer Committee of the Chinese Medical Doctor Association;Colorectal Cancer Committee of China Anti-Cancer Association;Natural Orifice Specimen Extraction Surgery (NOSES) Committee of China Anti-
In China, mid-to-low rectal cancers represent the majority of rectal cancer surgeries. Organ preservation, function preservation, and improvement of patients' quality of life are current directions in surgical development. The modified Baco...
[Expert consensus on primary tumor management for metastatic colorectal cancer (2026 edition)] [0.03%]
《转移性结直肠癌原发肿瘤处理专家共识（2026版）》
Chinese Watch & Wait Database Research Collaboration Group (CWWD);Chinese Society of Colorectal Surgery;Chinese Medical Association
Chinese Watch & Wait Database Research Collaboration Group (CWWD);Chinese Society of Colorectal Surgery;Chinese Medical Association
Advances in comprehensive treatment primarily based on drug therapy have significantly improved the prognosis of metastatic colorectal cancer (mCRC) in recent decades. Patients who undergo surgical resection or local treatment after convers...
[Research advances in the value of tertiary lymphoid structures for gastrointestinal tumors during the immunotherapy era] [0.03%]
免疫治疗时代胃肠肿瘤相关三级淋巴结构研究进展
Y W Sun,S C Ai,X F Shen et al.
Y W Sun et al.
In the era of tumor immunotherapy, Tertiary lymphoid structures (TLS) are ectopic lymphoid tissues in the tumor microenvironment, which are composed of B cell follicular regions and T cell regions, and their mature structures contain functi...
[Key updates in the 16th edition of the japanese classification of gastric carcinoma] [0.03%]
日本胃癌分期第16版修改要点
B Yu,Y K Wang,B T Zhang et al.
B Yu et al.
This article summarizes the major updates in the 16th edition of the Japanese Classification of Gastric Carcinoma. Based on its established framework, the revision enhances alignment with the 9th edition of the TNM staging system, the Japan...
[Prognosis analysis of patients with locally advanced gastric cancer complicated with diabetes] [0.03%]
局部进展期合并糖尿病胃癌患者的预后分析
Y Q Zhang,Y F Zhu,W H Zhang et al.
Y Q Zhang et al.
Objective: To investigate the clinicopathological characteristics, perioperative complications, and survival prognosis of patients with locally advanced gastric cancer complicated with diabetes mellitus (DM). Methods: A retrospective cohort...
[Construction of a predictive model for the efficacy of immune checkpoint inhibitors in locally advanced or metastatic gastric cancer and esophagogastric junction cancer] [0.03%]
[免疫检查点抑制剂治疗局部晚期或转移性胃及胃食管交界部癌疗效的预测模型构建]
C H Wu,F X Dong,Y K Wang et al.
C H Wu et al.
Objective: To develop and validate a predictive model for the efficacy of immune checkpoint inhibitors (ICI) in locally advanced or metastatic gastric or gastroesophageal junction cancer (G/GEJC) patients. Methods: This study was a retrospe...
[Conversion efficacy and safety analysis of PD-1 inhibitor combined with albumin-bound paclitaxel and SOX chemotherapy regimen in initially unresectable advanced gastric cancer] [0.03%]
免疫检查点抑制剂联合白蛋白紫杉醇和SOX化疗方案转化不可切除的局部进展期胃癌疗效及安全性分析
Y F Tang,B Q Zhou,B B Wen et al.
Y F Tang et al.
Objective: To evaluate the efficacy and safety of a PD-1 inhibitor combined with albumin-bound paclitaxel and the SOX chemotherapy regimen for the conversion therapy of initially unresectable advanced gastric cancer. Methods: This study was...